en

PRODUCT DETAIL

IMFINZI 50 mg/ml infúzny koncentrát

Code 9354C
MA number EU/1/18/1322/001
Product Form: con inf 1x10 ml/500 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
L01XC28 Durvalumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 21.09.2018
Validity: 21.09.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.10.2018
eu-flag.png sk-flag.png